These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 19384274)
1. Synthesis of new naphtho[2,3-f]quinoxaline-2,7,12(1H)-trione and anthra-9,10-quinone dyes from furan-2,3-diones. Ungören SH Molecules; 2009 Apr; 14(4):1429-37. PubMed ID: 19384274 [TBL] [Abstract][Full Text] [Related]
2. The first series of 4,11-bis[(2-aminoethyl)amino]anthra[2,3-b]furan-5,10-diones: Synthesis and anti-proliferative characteristics. Shchekotikhin AE; Glazunova VA; Dezhenkova LG; Shevtsova EK; Traven' VF; Balzarini J; Huang HS; Shtil AA; Preobrazhenskaya MN Eur J Med Chem; 2011 Jan; 46(1):423-8. PubMed ID: 21144624 [TBL] [Abstract][Full Text] [Related]
3. Quinoxaline-embedded polyacenoquinone esters: synthesis, electronic properties, and crystal structure. Chou TC; Lin KC; Kon-no M; Lee CC; Shinmyozu T Org Lett; 2011 Sep; 13(17):4588-91. PubMed ID: 21830827 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of quinoxaline-5,8-diones that inhibit vascular smooth muscle cell proliferation. Chung HJ; Jung OJ; Chae MJ; Hong SY; Chung KH; Lee SK; Ryu CK Bioorg Med Chem Lett; 2005 Jul; 15(14):3380-4. PubMed ID: 15950466 [TBL] [Abstract][Full Text] [Related]
5. Discovery of antitumor anthra[2,3-b]furan-3-carboxamides: Optimization of synthesis and evaluation of antitumor properties. Shchekotikhin AE; Dezhenkova LG; Tsvetkov VB; Luzikov YN; Volodina YL; Tatarskiy VV; Kalinina AA; Treshalin MI; Treshalina HM; Romanenko VI; Kaluzhny DN; Kubbutat M; Schols D; Pommier Y; Shtil AA; Preobrazhenskaya MN Eur J Med Chem; 2016 Apr; 112():114-129. PubMed ID: 26890118 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and cytotoxicity of 2-methyl-4, 9-dihydro-1-substituted-1H-imidazo[4,5-g]quinoxaline-4,9-diones and 2,3-disubstituted-5,10-pyrazino[2,3-g]quinoxalinediones. Yoo HW; Suh ME; Park SW J Med Chem; 1998 Nov; 41(24):4716-22. PubMed ID: 9822542 [TBL] [Abstract][Full Text] [Related]
7. In vitro antitubercular and antimicrobial activities of 1-substituted quinoxaline-2,3(1H,4H)-diones. Ramalingam P; Ganapaty S; Rao ChB Bioorg Med Chem Lett; 2010 Jan; 20(1):406-8. PubMed ID: 19962890 [TBL] [Abstract][Full Text] [Related]
8. 2-Substituted 3-methylnaphtho[1,2-b]furan-4,5-diones as novel L-shaped ortho-quinone substrates for NAD(P)H:quinone oxidoreductase (NQO1). Bian J; Deng B; Xu L; Xu X; Wang N; Hu T; Yao Z; Du J; Yang L; Lei Y; Li X; Sun H; Zhang X; You Q Eur J Med Chem; 2014 Jul; 82():56-67. PubMed ID: 24874653 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationships of lapacho analogues. 1. Suppression of human keratinocyte hyperproliferation by 2-substituted naphtho[2,3-b]furan-4,9-diones, activation by enzymatic one- and two-electron reduction, and intracellular generation of superoxide. Reichstein A; Vortherms S; Bannwitz S; Tentrop J; Prinz H; Müller K J Med Chem; 2012 Aug; 55(16):7273-84. PubMed ID: 22845014 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of the antiproliferative activity of novel isoindolo[2,1-a]quinoxaline and indolo[1,2-a]quinoxaline derivatives. Desplat V; Moreau S; Belisle-Fabre S; Thiolat D; Uranga J; Lucas R; de Moor L; Massip S; Jarry C; Mossalayi DM; Sonnet P; Déléris G; Guillon J J Enzyme Inhib Med Chem; 2011 Oct; 26(5):657-67. PubMed ID: 21250818 [TBL] [Abstract][Full Text] [Related]
11. An Efficient Synthesis of Naphtho[2,3- Tan H; Qi Z; Yu Y; Zhang X; Xiang Y; Huang J; Xu Z; Tang D; Chen Z; Wang B Molecules; 2023 Jun; 28(12):. PubMed ID: 37375306 [TBL] [Abstract][Full Text] [Related]
12. Organic Dyes Incorporating the Dithieno[3,2-f:2',3'-h]quinoxaline Moiety for Dye-Sensitized Solar Cells. Ni JS; Kao WS; Chou HJ; Lin JT ChemSusChem; 2015 Sep; 8(17):2932-9. PubMed ID: 25853981 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and alpha(1)-adrenoceptor antagonist activity of derivatives and isosters of the furan portion of (+)-cyclazosin. Sagratini G; Angeli P; Buccioni M; Gulini U; Marucci G; Melchiorre C; Leonardi A; Poggesi E; Giardinà D Bioorg Med Chem; 2007 Mar; 15(6):2334-45. PubMed ID: 17276073 [TBL] [Abstract][Full Text] [Related]
16. From simple quinoxalines to potent oxazolo[5,4-f]quinoxaline inhibitors of glycogen-synthase kinase 3 (GSK3). Lassagne F; Duguépéroux C; Roca C; Perez C; Martinez A; Baratte B; Robert T; Ruchaud S; Bach S; Erb W; Roisnel T; Mongin F Org Biomol Chem; 2019 Dec; 18(1):154-162. PubMed ID: 31803883 [TBL] [Abstract][Full Text] [Related]
17. An efficient synthesis of quinoxalinone derivatives as potent inhibitors of aldose reductase. Yang Y; Zhang S; Wu B; Ma M; Chen X; Qin X; He M; Hussain S; Jing C; Ma B; Zhu C ChemMedChem; 2012 May; 7(5):823-35. PubMed ID: 22416050 [TBL] [Abstract][Full Text] [Related]
18. Dye-sensitized photooxygenation of furanosyl furans: synthesis of a new pyridazine C-nucleoside. Cermola F; Iesce MR; Buonerba G J Org Chem; 2005 Aug; 70(16):6503-5. PubMed ID: 16050717 [TBL] [Abstract][Full Text] [Related]
19. Reactions of o-quinone methides with pyridinium methylides: a diastereoselective synthesis of 1,2-dihydronaphtho[2,1-b]furans and 2,3-dihydrobenzofurans. Osyanin VA; Osipov DV; Klimochkin YN J Org Chem; 2013 Jun; 78(11):5505-20. PubMed ID: 23668240 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of some new 4-styryltetrazolo[1,5-a]quinoxaline and 1-substituted-4-styryl[1,2,4]triazolo[4,3-a]quinoxaline derivatives as potent anticonvulsants. Wagle S; Adhikari AV; Kumari NS Eur J Med Chem; 2009 Mar; 44(3):1135-43. PubMed ID: 18672315 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]